Royal DSM, a global science-based company in nutrition, health and sustainable living has completed its acquisition of Erber Group's Biomin and Romer Labs for an enterprise value of €980 million. The transaction, first announced on June 12, forecasts enhanced earnings in the first year upon completion.

Biomin, a specialty animal nutrition and health business, specializes primarily in mycotoxin risk management and gut health performance. The acquisition of Biomin further strengthens DSM's expertise and reputation as a leading provider of animal health and nutrition solutions for farm productivity and sustainability, with an emphasis on emissions reduction, feed consumption efficiency and better use of water and land. It is therefore aligned closely with DSM's focus to make animal farming more sustainable from both an ecological and economical perspective.

The Romer Labs business focuses on food and feed safety diagnostic solutions. Romer Labs also complements DSM's human nutrition and health offering to customers in the food and beverage market segments. Both entities expand DSM's range of higher value-add specialty solutions.

DSM's purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders – customers, employees, shareholders and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam.

Source: Biomin, which is solely responsible for the information provided, and wholly owns the information. Informa Business Media and all its subsidiaries are not responsible for any of the content contained in this information asset.